Charles River Laboratories to Acquire Bioanalysis and DMPK Operations from Frontage Holdings
Acquiring Company
Charles River Laboratories
Acquired Company
Frontage Holdings Corporation
WilmingtonWest Whiteland TownshipBiotechnologyHealth CareScience And EngineeringPharmaceuticalBiotechnologyPharmaceuticalDescription
On November 9, 2026, Charles River Laboratories announced that it has entered into definitive agreements to acquire the bioanalysis and DMPK operations of Frontage Holdings Corporation located in Exton, Pennsylvania. This strategic acquisition will enhance Charles River's capabilities in the important area of drug development services. Financial terms of the deal have not been disclosed.
Who to call at Charles River Laboratories, and when
When Charles River Laboratories changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Charles River Laboratories raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Charles River Laboratories, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Charles River Laboratories. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Charles River Laboratories makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Frontage Holdings Corporation?
Frontage Holdings Corporation was acquired by Charles River Laboratories, based in Wilmington. The deal was reported on November 9, 2026. Charles River Laboratories is a leading provider of drug development services. The company specializes in preclinical and clinical laboratory services for the pharmaceutical and biotechnology industries. Charles River Laboratories is publicly traded (CRL) and operates in Biotechnology.
When did Charles River Laboratories acquire Frontage Holdings Corporation?
Charles River Laboratories's acquisition of Frontage Holdings Corporation was reported on November 9, 2026. On November 9, 2026, Charles River Laboratories announced that it has entered into definitive agreements to acquire the bioanalysis and DMPK operations of Frontage Holdings Corporation located in Exton, Pennsylvania. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Frontage Holdings Corporation do?
Frontage Holdings Corporation is a prominent provider of outsourced development services to the pharmaceutical and biotechnology industries. The company specializes in bioanalysis, drug metabolism and pharmacokinetics (DMPK), and regulatory support services. It is privately held, operating in Biotechnology, and is based in West Whiteland Township.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.